CN112587463A - Long-acting skin care composition for removing freckles and concealing blemishes and preparation method thereof - Google Patents
Long-acting skin care composition for removing freckles and concealing blemishes and preparation method thereof Download PDFInfo
- Publication number
- CN112587463A CN112587463A CN202010726814.9A CN202010726814A CN112587463A CN 112587463 A CN112587463 A CN 112587463A CN 202010726814 A CN202010726814 A CN 202010726814A CN 112587463 A CN112587463 A CN 112587463A
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- skin care
- care composition
- essential oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 42
- 208000003351 Melanosis Diseases 0.000 title claims abstract description 41
- 206010014970 Ephelides Diseases 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 239000000284 extract Substances 0.000 claims abstract description 125
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000000341 volatile oil Substances 0.000 claims abstract description 32
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000003814 drug Substances 0.000 claims abstract description 20
- LBQIJVLKGVZRIW-ZDUSSCGKSA-N glabridin Chemical compound C1([C@H]2CC3=CC=C4OC(C=CC4=C3OC2)(C)C)=CC=C(O)C=C1O LBQIJVLKGVZRIW-ZDUSSCGKSA-N 0.000 claims abstract description 20
- 229940093767 glabridin Drugs 0.000 claims abstract description 20
- PMPYOYXFIHXBJI-ZDUSSCGKSA-N glabridin Natural products C1([C@H]2CC=3C=CC4=C(C=3OC2)CCC(O4)(C)C)=CC=C(O)C=C1O PMPYOYXFIHXBJI-ZDUSSCGKSA-N 0.000 claims abstract description 20
- LBQIJVLKGVZRIW-UHFFFAOYSA-N glabridine Natural products C1OC2=C3C=CC(C)(C)OC3=CC=C2CC1C1=CC=C(O)C=C1O LBQIJVLKGVZRIW-UHFFFAOYSA-N 0.000 claims abstract description 20
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 17
- 235000011274 Benincasa cerifera Nutrition 0.000 claims abstract description 17
- 244000036905 Benincasa cerifera Species 0.000 claims abstract description 17
- 241001313857 Bletilla striata Species 0.000 claims abstract description 17
- 240000000249 Morus alba Species 0.000 claims abstract description 17
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 17
- 229960000458 allantoin Drugs 0.000 claims abstract description 17
- 229940107605 borage extract Drugs 0.000 claims abstract description 17
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 16
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 16
- 240000001851 Artemisia dracunculus Species 0.000 claims abstract description 16
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 16
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 16
- 241000220317 Rosa Species 0.000 claims abstract description 16
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 16
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229920001100 Polydextrose Polymers 0.000 claims abstract description 15
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 15
- 229940035035 polydextrose Drugs 0.000 claims abstract description 15
- 235000013856 polydextrose Nutrition 0.000 claims abstract description 15
- 239000001259 polydextrose Substances 0.000 claims abstract description 15
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000003880 Calendula Nutrition 0.000 claims abstract description 14
- 240000001432 Calendula officinalis Species 0.000 claims abstract description 14
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000008367 deionised water Substances 0.000 claims abstract description 13
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 13
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims abstract description 10
- 244000143149 Leptochloa chinensis Species 0.000 claims abstract description 8
- 229960003966 nicotinamide Drugs 0.000 claims abstract description 7
- 235000005152 nicotinamide Nutrition 0.000 claims abstract description 7
- 239000011570 nicotinamide Substances 0.000 claims abstract description 7
- 229940002386 calendula officinalis extract Drugs 0.000 claims abstract description 3
- 238000003756 stirring Methods 0.000 claims description 30
- 241000245665 Taraxacum Species 0.000 claims description 13
- 238000001816 cooling Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 244000061520 Angelica archangelica Species 0.000 claims description 5
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 5
- 241000229182 Ledebouriella seseloides Species 0.000 claims description 5
- 239000006286 aqueous extract Substances 0.000 claims description 5
- 230000002829 reductive effect Effects 0.000 claims description 5
- 230000005855 radiation Effects 0.000 claims description 4
- 230000005250 beta ray Effects 0.000 claims description 3
- 238000007599 discharging Methods 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000007689 inspection Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000005728 strengthening Methods 0.000 claims description 3
- 241001530121 Trollius Species 0.000 claims description 2
- 229940067866 dandelion extract Drugs 0.000 claims description 2
- 235000020691 dandelion extract Nutrition 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 239000001845 taraxacum officinale leaf extract Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 4
- 239000012676 herbal extract Substances 0.000 claims 1
- 241000411851 herbal medicine Species 0.000 claims 1
- 230000005923 long-lasting effect Effects 0.000 claims 1
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract description 30
- 239000005556 hormone Substances 0.000 abstract description 3
- 229940088597 hormone Drugs 0.000 abstract description 3
- 230000008021 deposition Effects 0.000 abstract description 2
- 240000001949 Taraxacum officinale Species 0.000 abstract 2
- 241001085205 Prenanthella exigua Species 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 39
- 238000012360 testing method Methods 0.000 description 13
- 230000002159 abnormal effect Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 206010008570 Chloasma Diseases 0.000 description 6
- 102000003425 Tyrosinase Human genes 0.000 description 5
- 108060008724 Tyrosinase Proteins 0.000 description 5
- 230000002087 whitening effect Effects 0.000 description 4
- 239000007854 depigmenting agent Substances 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 230000037311 normal skin Effects 0.000 description 3
- 208000037259 Amyloid Plaque Diseases 0.000 description 2
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- SGNZYJXNUURYCH-UHFFFAOYSA-N 5,6-dihydroxyindole Chemical compound C1=C(O)C(O)=CC2=C1NC=C2 SGNZYJXNUURYCH-UHFFFAOYSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 210000001787 dendrite Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/81—Preparation or application process involves irradiation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to a skin care composition, in particular to a long-acting skin care composition for removing freckles and concealing blemishes and a preparation method thereof, wherein the skin care composition comprises the following raw materials: calendula officinalis extract, bletilla striata extract, Chinese waxgourd stem extract, dandelion water extract, mulberry root extract, glabridin, borage extract, Chinese sprangletop extract, beta-methyl carboxylic acid polydextrose, nicotinamide, allantoin, rose essential oil, wormwood essential oil, traditional Chinese medicine extract and deionized water. The calendula extract, the bletilla striata extract, the Chinese waxgourd stem extract, the dandelion water extract, the mulberry root extract, the glabridin, the borage extract and the Chinese iris extract are compounded for use, and the beta-methyl carboxylic acid polydextrose, the nicotinamide and the allantoin are added, so that the free radicals can be effectively inhibited, the skin melanin deposition can be prevented and improved, the plaque can be relieved and lightened, and the skin can be recovered to be in a bright white and clean state; most raw materials are natural, no hormone is added, and the use is safe and relieved.
Description
Technical Field
The invention relates to a skin care composition, in particular to a long-acting skin care composition for removing freckles and concealing blemishes and a preparation method thereof.
Background
Melanin (melanin) is an important factor determining human skin color, and it is biosynthesized in melanosomes in melanocytes of the basal layer of the epidermis. Under normal physiological conditions, melanin in the skin protects the skin from ultraviolet light. When the melanin anabolism mechanism is disturbed due to external invasion, hormone imbalance, aging or other factors, the melanin in the basal layer of the epidermis is increased, the color of partial or whole skin is deepened, and pigmentation skin diseases such as freckle, chloasma, cyasma, senile plaque, melanoma and the like are caused, so that the appearance of a human is influenced. The biosynthesis steps of the melanin comprise: tyrosine in melanocyte tissue is converted into dopa under the action of tyrosinase, dopa is further converted into dopaquinone under the catalysis of tyrosinase, dopaquinone is further converted into dopachrome, 5, 6-dihydroxyindole, 5, 6-indoloquinone, and finally into melanin. Melanin granules are synthesized and transported by the dendrites into keratinocytes.
In the prior art, the freckle removing product is mainly used for chloasma, and most experts think that the chloasma can be related to the following factors: ultraviolet radiation, endocrine dyscrasia, heredity, oxygen free radicals, drugs and cosmetics, oral drugs, local micro-ecology, systemic pathological changes of organisms, emotional fluctuation and the like, and the specific pathogenesis of the diseases is not clear; whitening is required for removing freckles, and skin whitening agents usually take tyrosinase as an action target, and reduce the generation of skin melanin by inhibiting the activity of the tyrosinase or blocking the reaction of the tyrosinase to generate the melanin, so that the skin whitening effect is achieved. Most of the skin whitening agents adopt hydrogen peroxide, mercuric amino chloride and various phenolic derivatives as skin whitening agents, the compounds can rapidly break up melanin tissues to achieve the effect of rapid whitening, but have adverse effects of corrosivity, cytotoxicity, anaphylaxis and the like on skin, are poor in safety, not ideal in effect and large in skin irritation, and have the need of continuously researching freckle-removing cosmetics.
Disclosure of Invention
The invention aims to provide a long-acting skin care composition for removing freckles and concealing blemishes and a preparation method thereof.
In order to achieve the above object, the present invention adopts the following technical solutions
A long-acting skin care composition for removing freckles and concealing blemishes comprises the following raw materials: calendula officinalis extract, bletilla striata extract, Chinese waxgourd stem extract, dandelion water extract, mulberry root extract, glabridin, borage extract, Chinese sprangletop extract, beta-methyl carboxylic acid polydextrose, nicotinamide, allantoin, rose essential oil, wormwood essential oil, traditional Chinese medicine extract and deionized water.
Preferably, the long-acting skin care composition for removing the freckles and concealing the blemishes comprises the following raw materials in parts by weight: 2-10 parts of calendula extract, 2-10 parts of bletilla striata extract, 2-10 parts of Chinese waxgourd stem extract, 1-5 parts of dandelion water extract, 1-5 parts of mulberry root extract, 1-3 parts of glabridin, 1-5 parts of borage extract, 2-8 parts of Chinese sprangle extract, 0.6-1.5 parts of beta-methyl carboxylic acid polydextrose, 0.3-1.0 part of nicotinamide, 0.6-1.2 parts of allantoin, 0.6-1.4 parts of rose essential oil, 0.3-0.8 part of wormwood essential oil, 2-4 parts of traditional Chinese medicine extract and 30-50 parts of deionized water.
Preferably, the long-acting skin care composition for removing the freckles and concealing the blemishes comprises the following raw materials in parts by weight: 6 parts of calendula extract, 6 parts of bletilla striata extract, 6 parts of Chinese waxgourd stem extract, 3 parts of dandelion water extract, 3 parts of mulberry root extract, 2 parts of glabridin, 3 parts of borage extract, 5 parts of Chinese sprangletop extract, 1.0 part of beta-methyl carboxylic acid polydextrose, 0.7 part of nicotinamide, 0.9 part of allantoin, 1.0 part of rose essential oil, 0.6 part of wormwood essential oil, 3 parts of traditional Chinese medicine extract and 40 parts of deionized water.
Preferably, the calendula extract, bletilla striata extract, Chinese waxgourd stem extract, dandelion aqueous extract, mulberry root extract, glabridin, borage extract, Chinese iris extract and Chinese medicinal extract are subjected to ultramicro molecular grinding, and the particle size is not more than 40 nm.
Preferably, the weight ratio of the traditional Chinese medicine extract is (1-2): 1 a mixture of an extract of ledebouriella seseloides and an extract of angelica.
Preferably, the solvent of the Chinese medicinal extract is CO2The supercritical fluid extract of (1).
A preparation method of a long-acting skin care composition for removing freckles and concealing blemishes comprises the following steps:
s1, putting deionized water into a stirring pot at room temperature, starting the stirring pot, rotating at the speed of 50-100r/min, sequentially and slowly adding the calendula extract, the bletilla striata extract, the Chinese waxgourd stem extract, the dandelion extract, the mulberry root extract, the glabridin, the borage extract, the malacopa extract and the traditional Chinese medicine extract, and stirring until the mixture is completely mixed and dissolved;
s2, heating to 50-65 ℃, sequentially adding glabridin and beta-methyl carboxylic acid polydextrose, continuing stirring at the rotating speed of 80-160r/min, uniformly stirring, and keeping the temperature for 20 min;
s3, after heat preservation is finished, cooling while stirring, adding nicotinamide and allantoin when the temperature is reduced to 40-45 ℃, keeping the temperature and continuously stirring until the nicotinamide and the allantoin are completely mixed and dissolved, and achieving a homogeneous state;
s4, after uniformly stirring, adjusting the rotation speed to 30-50r/min, naturally cooling to room temperature, adding rose essential oil and wormwood essential oil, and continuously stirring until the rose essential oil and the wormwood essential oil are completely mixed and dissolved to reach a homogeneous state;
and S5, checking, filtering and discharging after the inspection is qualified, and sealing for later use.
Preferably, in S2, the solution in the heat preservation state is treated by magnetic field strengthening technology for 20min, and the magnetic field intensity is 80-150 mT.
Preferably, in S2 and S3, the heating is assisted by heat radiation, and the wavelength of the electromagnetic wave is 200-.
Preferably, in S4, beta-ray irradiation is used for 3-5min during stirring.
The invention has the beneficial effects that:
1. according to the invention, the calendula extract, the bletilla striata extract, the Chinese waxgourd stem extract, the dandelion aqueous extract, the mulberry root extract, the glabridin, the borage extract and the Chinese iris extract are compounded for use, and the beta-methyl carboxylic acid polydextrose, the nicotinamide and the allantoin are added, so that the free radicals can be effectively inhibited, the skin melanin deposition can be prevented and improved, the plaque can be relieved and lightened, and the skin can be recovered to be in a bright, white and clean state.
2. The traditional Chinese medicine whitening component is added, so that the discharge of melanin can be accelerated from the inner part of the skin and the cell layer, and after the melanin is smoothly discharged, plaques are naturally lightened.
3. Most raw materials come from nature, no hormone is added, the use is safe and safe, and secondary damage to skin can not be caused.
4. Can be used for treating pigmentation dermatoses such as freckle, chloasma, cyasma, senile plaque, and melanoma.
Detailed Description
The technical solutions in the embodiments of the present invention are clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1:
a long-acting skin care composition for removing freckles and concealing blemishes comprises the following raw materials in parts by weight: 2 parts of calendula extract, 10 parts of bletilla striata extract, 2 parts of Chinese waxgourd stem extract, 5 parts of dandelion aqueous extract, 1 part of mulberry root extract, 3 parts of glabridin, 1 part of borage extract, 8 parts of Chinese sprangletop extract, 0.6 part of beta-methyl carboxylic acid polydextrose, 1.0 part of nicotinamide, 0.6 part of allantoin, 1.4 parts of rose essential oil, 0.3 part of wormwood essential oil, 4 parts of traditional Chinese medicine extract and 30 parts of deionized water.
Wherein, the weight ratio of the traditional Chinese medicine extract is 1: 1 a mixture of an extract of ledebouriella seseloides and an extract of angelica.
Example 2:
a long-acting skin care composition for removing freckles and concealing blemishes comprises the following raw materials in parts by weight: 6 parts of calendula extract, 6 parts of bletilla striata extract, 6 parts of Chinese waxgourd stem extract, 3 parts of dandelion water extract, 3 parts of mulberry root extract, 2 parts of glabridin, 3 parts of borage extract, 5 parts of Chinese sprangletop extract, 1.0 part of beta-methyl carboxylic acid polydextrose, 0.7 part of nicotinamide, 0.9 part of allantoin, 1.0 part of rose essential oil, 0.6 part of wormwood essential oil, 3 parts of traditional Chinese medicine extract and 40 parts of deionized water.
Wherein, the weight ratio of the traditional Chinese medicine extract is 2: 1 a mixture of an extract of ledebouriella seseloides and an extract of angelica.
Example 3:
a long-acting skin care composition for removing freckles and concealing blemishes comprises the following raw materials in parts by weight: 10 parts of calendula extract, 2 parts of bletilla striata extract, 10 parts of Chinese waxgourd stem extract, 1 part of dandelion aqueous extract, 5 parts of mulberry root extract, 1 part of glabridin, 5 parts of borage extract, 2 parts of Chinese sprangletop extract, 1.5 parts of beta-methyl carboxylic acid polydextrose, 0.3 part of nicotinamide, 1.2 parts of allantoin, 0.6 part of rose essential oil, 0.8 part of wormwood essential oil, 4 parts of traditional Chinese medicine extract and 50 parts of deionized water.
Wherein, the weight ratio of the traditional Chinese medicine extract is 1: 1 a mixture of an extract of ledebouriella seseloides and an extract of angelica.
The preparation method of the long-acting skin care composition for removing freckles and concealing blemishes in the embodiment 1-3 comprises the following steps:
s1, putting deionized water into a stirring pot at room temperature, starting the stirring pot, rotating at the speed of 80r/min, sequentially and slowly adding the calendula extract, the bletilla striata extract, the Chinese waxgourd stem extract, the dandelion water extract, the mulberry root extract, the glabridin, the borage extract, the Chinese globeflower herb extract and the traditional Chinese medicine extract, and stirring until the mixture is completely mixed and dissolved;
s2, heating to 55 ℃, sequentially adding glabridin and beta-methyl carboxylic acid polydextrose, continuing stirring at a rotation speed of 120r/min, uniformly stirring, and keeping the temperature for 20 min;
s3, after heat preservation is finished, cooling while stirring, adding nicotinamide and allantoin when the temperature is reduced to 40 ℃, keeping stirring continuously until the mixture is completely dissolved and mixed, and achieving a homogeneous state;
s4, after uniformly stirring, adjusting the rotating speed to 40r/min, naturally cooling to room temperature, adding rose essential oil and wormwood essential oil, and continuously stirring until the rose essential oil and the wormwood essential oil are completely mixed and dissolved to reach a homogeneous state;
and S5, checking, filtering and discharging after the inspection is qualified, and sealing for later use.
In order to improve the preparation effect, in S2, the solution in the heat preservation state is treated by adopting a magnetic field strengthening technology, the time is 20min, and the magnetic field intensity is 80-150 mT; under the action of the magnetic field, the molecular motion speed is accelerated, and the small liquid drops are promoted to generate internal circulation, so that various substances are more thoroughly homogenized, and the molecular dispersion degree is higher.
In S2 and S3, heat radiation is used for auxiliary heating, the wavelength of electromagnetic waves is 200-.
In S4, beta-ray irradiation is used for 3-5min during stirring to promote modification and crosslinking reaction of acid ester alcohol, thereby improving the use effect.
Experimental example 1
Allergy test
Experimental mode: selecting 30 volunteers, dividing the gauze into three groups, dividing the gauze into a plurality of small blocks of about 1 square centimeter, soaking the small blocks in distilled water, coating the long-acting skin care composition for removing freckles and covering blemishes prepared in the example 1-3 on one surface of the gauze, then respectively applying the long-acting skin care composition on five normal skins on the forearms and the backs of the volunteers, covering the five normal skins with 1.5 square centimeter airtight plastic films, and fixing the five normal skins with adhesive tapes. After one day, the gauze is removed and cleaned, observation is carried out, if abnormality such as erythema, pruritus, burning pain or redness and swelling occurs at a test position, the long-acting skin care combination for removing the freckles and covering the blemishes is proved to have irritation, and if the abnormality does not occur, the long-acting skin care combination for removing the freckles and covering the blemishes is proved to have no irritation. The results of the experiment are shown in table 1:
volunteers 1 group | 2 groups of volunteers | Volunteers 3 groups | |
Example 1 | Abnormal condition of test part | Abnormal condition of test part | Abnormal condition of test part |
Example 2 | Abnormal condition of test part | Abnormal condition of test part | Abnormal condition of test part |
Example 3 | Abnormal condition of test part | Abnormal condition of test part | Abnormal condition of test part |
TABLE 1
The experimental results in table 1 show that the long-acting skin care combination for removing freckles and covering prepared by the invention has no irritation to 1-3 groups of volunteers, which indicates that the long-acting skin care combination for removing freckles and covering prepared by the invention is safe to use.
Experimental example two
Clinical use case
Case 1, a person who is higher than the skin is a male, the person is 46 years old, and the face is determined to be chloasma in 2018, the long-acting skin care composition for removing the freckles and covering the blemishes prepared in example 2 is used from 3 months in 2019, the composition is applied after face washing every day, the composition is used once in the morning and evening, the blemishes are rechecked after 1 month, the freckles on the face become pale, after 3 months, part of the plaques almost disappear, the areas of other plaques are obviously reduced, after 6 months, the plaques basically disappear, the person is continuously used for 3 months, and the freckles.
Case 2, a certain woman, 38 years old, the left face appears spots from 2015, the number and the area of the left face are increased along with the increase of time, part of the left face gradually expands into pieces, and the multi-part treatment does not obviously improve, the long-acting skin care composition for removing the spots and covering the spots prepared in the example 2 is used from 2019 and 5 months, the long-acting skin care composition is applied after face washing every day, the skin care composition is used once in the morning and at night, the investigation is repeated after 1 month, the spots on the face become light, some small spots disappear after 3 months, the skin color of the face is recovered, the skin color continuously improves after 6 months, the number and the area of the spots are greatly reduced, the spots are almost disappeared in 9 months, the skin color of the spot position is not greatly different from that of other positions, and the.
Clinical cases show that the long-acting skin care composition for removing the freckles and concealing the blemishes, prepared by the invention, has good relieving and treating effects on symptoms such as facial stains, chloasma and the like.
Experimental example III
Some performance index tests were performed on the long-acting skin care combinations of the spot removing concealers of examples 1 to 3, and the test results were as follows:
1, appearance: white flowable fine paste.
2, fragrance type: the plant has faint scent.
3 viscosity 6000-.
4 Cold stability test (48 ℃ X24 h): and (4) passing.
5 Cold resistance stability test (-15 ℃ X24 h): and (4) passing.
In the description herein, references to the description of "one embodiment," "an example," "a specific example" or the like are intended to mean that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the invention. In this specification, the schematic representations of the terms used above do not necessarily refer to the same embodiment or example. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.
Finally, it should be noted that the above-mentioned preferred embodiments of the present invention are provided merely to help illustrate the present invention. The preferred embodiments are not intended to be exhaustive or to limit the invention to the precise embodiments disclosed. Obviously, many modifications and variations are possible in light of the above teaching. The embodiments were chosen and described in order to best explain the principles of the invention and the practical application, to thereby enable others skilled in the art to best utilize the invention. The invention is limited only by the claims and their full scope and equivalents.
Claims (10)
1. The long-acting skin care composition for removing freckles and concealing blemishes is characterized by comprising the following raw materials: calendula officinalis extract, bletilla striata extract, Chinese waxgourd stem extract, dandelion water extract, mulberry root extract, glabridin, borage extract, Chinese sprangletop extract, beta-methyl carboxylic acid polydextrose, nicotinamide, allantoin, rose essential oil, wormwood essential oil, traditional Chinese medicine extract and deionized water.
2. The long-acting skin care composition for removing freckles and concealing blemishes, according to claim 1, is characterized by comprising the following raw materials in parts by weight: 2-10 parts of calendula extract, 2-10 parts of bletilla striata extract, 2-10 parts of Chinese waxgourd stem extract, 1-5 parts of dandelion water extract, 1-5 parts of mulberry root extract, 1-3 parts of glabridin, 1-5 parts of borage extract, 2-8 parts of Chinese sprangle extract, 0.6-1.5 parts of beta-methyl carboxylic acid polydextrose, 0.3-1.0 part of nicotinamide, 0.6-1.2 parts of allantoin, 0.6-1.4 parts of rose essential oil, 0.3-0.8 part of wormwood essential oil, 2-4 parts of traditional Chinese medicine extract and 30-50 parts of deionized water.
3. The long-acting skin care composition for removing freckles and concealing blemishes, according to claim 2, is characterized by comprising the following raw materials in parts by weight: 6 parts of calendula extract, 6 parts of bletilla striata extract, 6 parts of Chinese waxgourd stem extract, 3 parts of dandelion water extract, 3 parts of mulberry root extract, 2 parts of glabridin, 3 parts of borage extract, 5 parts of Chinese sprangletop extract, 1.0 part of beta-methyl carboxylic acid polydextrose, 0.7 part of nicotinamide, 0.9 part of allantoin, 1.0 part of rose essential oil, 0.6 part of wormwood essential oil, 3 parts of traditional Chinese medicine extract and 40 parts of deionized water.
4. The long-acting skin care composition for removing freckles and concealing blemishes as claimed in claim 1, wherein calendula extract, bletilla striata extract, wax gourd vine extract, dandelion aqueous extract, mulberry root extract, glabridin, borage extract, Chinese globeflower extract and chinese herbal medicine extract are all subjected to ultra-micro molecular grinding, and the particle size is not more than 40 nm.
5. The long-acting skin care composition for removing freckles and concealing blemishes according to claim 1, wherein the traditional Chinese medicine extract is prepared from the following raw materials in parts by weight (1-2): 1 a mixture of an extract of ledebouriella seseloides and an extract of angelica.
6. The long-acting skin care composition for removing freckles and concealing blemishes according to claim 1, wherein the solvent of the herbal extract is CO2The supercritical fluid extract of (1).
7. A method of preparing a spot removing concealer combination for long-lasting skin care according to any of claims 1 to 6, comprising the steps of:
s1, putting deionized water into a stirring pot at room temperature, starting the stirring pot, rotating at the speed of 50-100r/min, sequentially and slowly adding the calendula extract, the bletilla striata extract, the Chinese waxgourd stem extract, the dandelion extract, the mulberry root extract, the glabridin, the borage extract, the malacopa extract and the traditional Chinese medicine extract, and stirring until the mixture is completely mixed and dissolved;
s2, heating to 50-65 ℃, sequentially adding glabridin and beta-methyl carboxylic acid polydextrose, continuing stirring at the rotating speed of 80-160r/min, uniformly stirring, and keeping the temperature for 20 min;
s3, after heat preservation is finished, cooling while stirring, adding nicotinamide and allantoin when the temperature is reduced to 40-45 ℃, keeping the temperature and continuously stirring until the nicotinamide and the allantoin are completely mixed and dissolved, and achieving a homogeneous state;
s4, after uniformly stirring, adjusting the rotation speed to 30-50r/min, naturally cooling to room temperature, adding rose essential oil and wormwood essential oil, and continuously stirring until the rose essential oil and the wormwood essential oil are completely mixed and dissolved to reach a homogeneous state;
and S5, checking, filtering and discharging after the inspection is qualified, and sealing for later use.
8. The method for preparing the long-acting skin care composition for removing freckles and concealers according to claim 7, wherein in S2, the solution in the heat preservation state is treated by a magnetic field strengthening technology for 20min, and the magnetic field intensity is 80-150 mT.
9. The method as claimed in claim 7, wherein the heat radiation is used for heating assistance in S2 and S3, and the wavelength of electromagnetic wave is 200-.
10. The method for preparing the long-acting skin care composition for removing freckles and concealers as claimed in claim 7, wherein in S4, beta-ray irradiation is used for 3-5min during stirring.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010726814.9A CN112587463A (en) | 2020-07-26 | 2020-07-26 | Long-acting skin care composition for removing freckles and concealing blemishes and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010726814.9A CN112587463A (en) | 2020-07-26 | 2020-07-26 | Long-acting skin care composition for removing freckles and concealing blemishes and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112587463A true CN112587463A (en) | 2021-04-02 |
Family
ID=75180063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010726814.9A Pending CN112587463A (en) | 2020-07-26 | 2020-07-26 | Long-acting skin care composition for removing freckles and concealing blemishes and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112587463A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104905996A (en) * | 2014-03-10 | 2015-09-16 | 玫琳凯有限公司 | Skin Lightening Compositions |
CN109248135A (en) * | 2018-11-16 | 2019-01-22 | 广东圣蜜生物科技有限公司 | A kind of sheen highlights, the external-use skin care of concealing moisturizing combination and preparation method thereof |
CN110339124A (en) * | 2019-08-22 | 2019-10-18 | 台州市奥拉克医疗美容整形门诊部有限公司 | A kind of cosmetic face cream and preparation method thereof for whitening spot-removing |
CN110522696A (en) * | 2019-09-26 | 2019-12-03 | 杨素芳 | A kind of plant spot-removing facial cleanser and preparation method thereof |
-
2020
- 2020-07-26 CN CN202010726814.9A patent/CN112587463A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104905996A (en) * | 2014-03-10 | 2015-09-16 | 玫琳凯有限公司 | Skin Lightening Compositions |
CN109248135A (en) * | 2018-11-16 | 2019-01-22 | 广东圣蜜生物科技有限公司 | A kind of sheen highlights, the external-use skin care of concealing moisturizing combination and preparation method thereof |
CN110339124A (en) * | 2019-08-22 | 2019-10-18 | 台州市奥拉克医疗美容整形门诊部有限公司 | A kind of cosmetic face cream and preparation method thereof for whitening spot-removing |
CN110522696A (en) * | 2019-09-26 | 2019-12-03 | 杨素芳 | A kind of plant spot-removing facial cleanser and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
李时珍: "《本草纲目》", 31 January 2018 * |
蔡燕萍: "《自然美容术 新版》", 31 July 1999 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20140206842A1 (en) | Peptides Modified with Triterpenoids and Small Organic Molecules: Synthesis and use in Cosmeceutical | |
CN110623882A (en) | Whitening and freckle removing mask and preparation method thereof | |
KR20120083943A (en) | Composition of skin external application containing propanoid derivatives | |
KR101810231B1 (en) | Cosmetic composition for improving acne containing propolis spicule powder | |
WO2008139182A2 (en) | Skin care composition | |
WO2023024289A1 (en) | Composition with whitening effect, and preparation method therefor and use thereof | |
CN113616575A (en) | Composite azelaic acid emulsion for preventing allergy and removing acne and preparation method thereof | |
EP3203977B1 (en) | Dermatological kit comprising compositions based on hibiscus flower and buriti oil | |
US20070003582A1 (en) | Medicine for the treatment of acne and for reversing the signs of age and sun damage and method for using same | |
JP2004529951A (en) | Pharmaceutical and cosmetic formulations for preventing skin aging | |
KR101096779B1 (en) | Cosmetic composition for skin beauty and manufacturing method thereof | |
CN108938511B (en) | Composition of natural plant extracts and application of composition in skin moisturizing and acne removing products | |
CN112472629A (en) | Alpinia officinarum and amomum tsao-ko sun-proof emulsion and preparation method thereof | |
KR102226179B1 (en) | Cosmetic Compositions for Anti-aging Comprising Extracts of Plants | |
JP2006193487A (en) | Cosmetic | |
CN112587463A (en) | Long-acting skin care composition for removing freckles and concealing blemishes and preparation method thereof | |
KR101481208B1 (en) | Composition for skin external application comprising cryptotanshinone as the active ingredient | |
CN113925820A (en) | Skin-whitening, freckle-removing and skin-protecting composition and preparation method thereof | |
CN113693966A (en) | Innovative whitening brightening freckle-removing cream and preparation method thereof | |
WO2015078398A1 (en) | Chinese herbal medicine compound for repairing ultraviolet damage, and uses thereof in cosmetics | |
KR20200080687A (en) | Composition For External Skin Application For Preventing Pigmentation and Promoting Skin Regeneration and a Manufacturing Method Thereof | |
KR100414903B1 (en) | Cosmetic composition containing medical plant complex extracts with antiwrinkle and whitening effect | |
KR100861415B1 (en) | Method of preparing cosmetics composition and cosmetics for anti-oxidation and skin-calming, prepared therefrom | |
CN110327268A (en) | Composition and its application in the personal care product of preparation anti-aging | |
KR100502069B1 (en) | Non-woven fabric pack impregnated with crude saponin of red ginseng for the improvement of acne |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210402 |